Medicine and Dentistry
Neoplasm
100%
Colorectal Carcinoma
69%
Rectum Cancer
60%
Chemoradiotherapy
54%
Esophageal Squamous Cell Carcinoma
54%
Disease Free Survival
46%
Overall Survival
37%
Mesenchymal-Epithelial Transition
27%
Prognostic Factor
25%
Immunohistochemistry
24%
Recurrent Disease
24%
Carcinoma
20%
DNA Mismatch Repair
19%
Multivariate Analysis
19%
Protein P53
18%
Colon Carcinoma
17%
Cancer Associated Fibroblast
17%
Protein Expression
17%
Transitional Cell Carcinoma
17%
Clinical Significance
16%
Promoter Region
16%
Breast Cancer
16%
Metastatic Carcinoma
15%
Adenocarcinoma
14%
Survival Rate
14%
Lymph Node Metastasis
14%
Carcinoembryonic Antigen
13%
Hedgehog Signaling
12%
Transcription Factor
12%
Tumor Cell
12%
Bladder
12%
Carcinogenesis
12%
Hazard Ratio
12%
Stomach Carcinoma
11%
Signaling Molecule
11%
Liver Metastasis
11%
Solid Malignant Neoplasm
11%
Cell Cycle
11%
Diseases
11%
Gene Expression
11%
Keloid
10%
Haematoxylin
10%
Eosin
10%
Endometrium
10%
Squamous Cell Carcinoma
10%
Hepatocellular Carcinoma
10%
Drug Delivery System
10%
Sonic Hedgehog Protein
10%
Cancer Cell
10%
Methylation
10%
Biochemistry, Genetics and Molecular Biology
Mesenchymal-Epithelial Transition
29%
Cancer Cell
29%
Disease Free Survival
27%
Fibroblast
26%
Overall Survival
25%
Promoter Region
25%
Colon
25%
Carcinogenesis
24%
Protein Expression
21%
Downregulation
20%
CD99
19%
Catenin
18%
Genomics
18%
Methylation
17%
Recurrence Free Survival
14%
Microsatellite Instability
14%
Transcription Factor
13%
Claudin
12%
Wild Type
12%
Estrogen Receptor
12%
Next Generation Sequencing
11%
Messenger RNA
11%
Multivariate Analysis
11%
Cell Cycle
11%
Metaplasia
10%
SET Domain
10%
Cancer Growth Factor
10%
Gene Promoter
10%
P53
10%
Cyclin D1
10%
Nude Mouse
10%
Programmed Cell Death
10%
Carcinoembryonic Antigen
9%
Tumor Progression
9%
Tenascin C
9%
KRAS
9%
Cetuximab
9%
Upregulation
8%
Differentially Expressed Gene
8%
Multigene Family
8%
Tissue Microarray
7%
Growth Factor Signaling
7%
Disease Specific Survival
7%
Cadherin
7%
Cancer Staging
6%
Fluorescence in Situ Hybridization
6%
Signal Transduction
6%
Sirtuin1
6%
DNA Sequence
6%
Survival Rate
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
53%
Colorectal Carcinoma
46%
Rectum Cancer
32%
Chemoradiation Therapy
32%
Colon Carcinoma
23%
Disease Free Survival
22%
Overall Survival
19%
Malignant Neoplasm
17%
Liver Cell Carcinoma
16%
Esophageal Squamous Cell Carcinoma
16%
Transitional Cell Carcinoma
16%
Tumor Growth
15%
Stomach Carcinoma
14%
Recurrent Disease
12%
Biological Marker
12%
Protein P53
12%
Carcinoma
12%
Esophagus Cancer
12%
Uvomorulin
12%
Carcinoembryonic Antigen
11%
Claudin 4
11%
Recurrence Free Survival
11%
Trophoblastic Disease
10%
Cancer Growth Factor
10%
Vimentin
10%
Adenocarcinoma
9%
Catenin
9%
Carcinogenesis
9%
Perineural Invasion
8%
Phosphotransferase
7%
Choriocarcinoma
7%
calcium activated,phospholipid dependent protein kinase
7%
Protein Kinase B
7%
Cetuximab
7%
Endometrium Carcinoma
6%
Hedgehog
6%
Small Interfering RNA
6%
Liver Metastasis
6%
Epidermal Growth Factor Receptor
6%
Irinotecan
6%
Messenger RNA
5%
Chemotherapy
5%
Ulcerative Colitis
5%
Serine Proteinase
5%
Epitope
5%
Glioblastoma
5%
Monocyte Chemotactic Protein 3
5%
Cisplatin
5%
Lung Cancer
5%
Therapeutic Effect
5%